NFE2L2 and type 2 diabetes mellitus: To further demonstrate the key role of Nrf2 in hUCMSC-mediated anti-apoptotic activity in type 2 diabetes, we used RNA interference to inhibit the expression of Nrf2 and evaluated the effect of hUCMSCs on oxidative damage and apoptosis in hGMCs (Fig. 6).